AliveCor Paving the Way For A New Generation of AI-Powered Remote Cardiology MOUNTAIN VIEW, Calif., Nov. 23, 2020 /PRNewswire/ — AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced that the US FDA had given clearance to the company’s next generation of interpretive ECG algorithms. “Kardia […]
Other News
Inovytec and Israel Defense Forces Partner to Advance Military Ventilator Capabilities
Inovytec’s Ventway Sparrow Increases Mobility while Maintaining High-Performance Ventilation, Making it Ideal for Soldiers in the Field RA’ANANA, Israel, Nov. 23, 2020 /PRNewswire/ — Inovytec, a developer of cutting-edge, first-line respiratory and cardiac medical solutions, announced today that the Ventway Sparrow (Ventway) MIL Standard model, a lightweight tactical ventilator, has been deployed by the Israel Defense […]
Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics
THOUSAND OAKS, Calif., Nov. 23, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the Company has provided notice to Cytokinetics of termination of its collaboration and its intention to transition the development and commercialization rights for omecamtiv mecarbil and AMG 594. Omecamtiv mecarbil, an investigational selective cardiac myosin activator, was studied in GALACTIC-HF, […]
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring
In combination with its newly opened independent diagnostic testing facility, VitalConnect is advancing how patients are monitored for cardiac arrhythmias SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter […]
Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism
Lightning 12 and Separator 12 Now Indicated for Treatment of PE ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the latest iteration of the Indigo® Aspiration System, Lightning™ 12. As part of […]
GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT) CHICAGO–(BUSINESS WIRE)–GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up specializing in photon counting detectors, signifying the […]
Aziyo Biologics Reports Third Quarter 2020 Financial Results
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2020. Recent […]
Cytokinetics Names Nancy Wysenski to Board of Directors
Appointment Strengthens Commercial, Market Access and Specialty Sales Expertise as Company Advances Pipeline Toward Potential Commercialization SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Nancy Wysenski has been appointed to the company’s Board of Directors. Ms. Wysenski brings more than 25 years […]
Caption Health Receives $4.95M Grant to Develop AI-Guided Lung Ultrasound System
Grant from the Bill & Melinda Gates Foundation will be leveraged to create new AI technology that allows medical professionals without prior ultrasound experience to perform lung ultrasounds, expanding access to quality medical care BRISBANE, Calif., Nov. 12, 2020 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company, today announced that […]
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
Significant Reduction in Triglyceride Levels Without Low-Density Lipoprotein Cholesterol (LDL-C) Increase Compared to Placebo and Safety Profile Similar to Placebo Achieved with 4 Grams Per Day Dose of Icosapent Ethyl in Chinese Patients with Very High Triglycerides (>500 mg/dL) Results Support Upcoming Submission by Partner, Edding, Seeking Regulatory Approval in China DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today shared positive, statistically […]



